BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayoob AM, Borenstein JT. The role of intracochlear drug delivery devices in the management of inner ear disease. Expert Opin Drug Deliv 2015;12:465-79. [PMID: 25347140 DOI: 10.1517/17425247.2015.974548] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Mäder K, Lehner E, Liebau A, Plontke SK. Controlled drug release to the inner ear: Concepts, materials, mechanisms, and performance. Hear Res 2018;368:49-66. [PMID: 29576310 DOI: 10.1016/j.heares.2018.03.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
2 Plontke SK. Diagnostics and therapy of sudden hearing loss. GMS Curr Top Otorhinolaryngol Head Neck Surg 2017;16:Doc05. [PMID: 29503670 DOI: 10.3205/cto000144] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
3 Agrahari V, Agrahari V, Mitra AK. Inner ear targeted drug delivery: what does the future hold? Therapeutic Delivery 2017;8:179-84. [DOI: 10.4155/tde-2017-0001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Peppi M, Marie A, Belline C, Borenstein JT. Intracochlear drug delivery systems: a novel approach whose time has come. Expert Opin Drug Deliv 2018;15:319-24. [PMID: 29480039 DOI: 10.1080/17425247.2018.1444026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
5 Ayoob AM, Peppi M, Tandon V, Langer R, Borenstein JT. A fluorescence-based imaging approach to pharmacokinetic analysis of intracochlear drug delivery. Hear Res 2018;368:41-8. [PMID: 29661614 DOI: 10.1016/j.heares.2018.03.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Frisina RD, Budzevich M, Zhu X, Martinez GV, Walton JP, Borkholder DA. Animal model studies yield translational solutions for cochlear drug delivery. Hear Res 2018;368:67-74. [PMID: 29793764 DOI: 10.1016/j.heares.2018.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
7 Kandathil CK, Stakhovskaya O, Leake PA. Effects of brain-derived neurotrophic factor (BDNF) on the cochlear nucleus in cats deafened as neonates. Hear Res 2016;342:134-43. [PMID: 27773647 DOI: 10.1016/j.heares.2016.10.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Salt AN, Plontke SK. Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications. Hear Res 2018;368:28-40. [PMID: 29551306 DOI: 10.1016/j.heares.2018.03.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 14.0] [Reference Citation Analysis]
9 Plontke SK, Götze G, Rahne T, Liebau A. Intracochleäre Medikamentenapplikation in Verbindung mit Cochleaimplantaten: Aktuelle Aspekte. HNO 2016;64:797-807. [DOI: 10.1007/s00106-016-0257-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Plontke SK, Götze G, Rahne T, Liebau A. Intracochlear drug delivery in combination with cochlear implants : Current aspects. HNO 2017;65:19-28. [PMID: 27933352 DOI: 10.1007/s00106-016-0285-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
11 Ayoob AM, Peppi M, Tandon V, Langer R, Borenstein JT. Intracochlear drug delivery: Fluorescent tracer evaluation for quantification of distribution in the cochlear partition. Eur J Pharm Sci 2019;126:49-58. [PMID: 30195649 DOI: 10.1016/j.ejps.2018.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Sircoglou J, Gehrke M, Tardivel M, Siepmann F, Siepmann J, Vincent C. Trans-Oval-Window Implants, A New Approach for Drug Delivery to the Inner Ear: Extended Dexamethasone Release From Silicone-based Implants. Otol Neurotol 2015;36:1572-9. [PMID: 26375981 DOI: 10.1097/MAO.0000000000000855] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
13 Froehlich MH, Lambert PR. The Physiologic Role of Corticosteroids in Menière's Disease: An Update on Glucocorticoid-mediated Pathophysiology and Corticosteroid Inner Ear Distribution. Otol Neurotol 2020;41:271-6. [PMID: 31821251 DOI: 10.1097/MAO.0000000000002467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 El Kechai N, Agnely F, Mamelle E, Nguyen Y, Ferrary E, Bochot A. Recent advances in local drug delivery to the inner ear. Int J Pharm 2015;494:83-101. [PMID: 26260230 DOI: 10.1016/j.ijpharm.2015.08.015] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 11.0] [Reference Citation Analysis]
15 Rathnam C, Chueng SD, Ying YM, Lee KB, Kwan K. Developments in Bio-Inspired Nanomaterials for Therapeutic Delivery to Treat Hearing Loss. Front Cell Neurosci 2019;13:493. [PMID: 31780898 DOI: 10.3389/fncel.2019.00493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
16 Liu X, Li M, Smyth H, Zhang F. Otic drug delivery systems: formulation principles and recent developments. Drug Dev Ind Pharm 2018;44:1395-408. [PMID: 29659300 DOI: 10.1080/03639045.2018.1464022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
17 Sun W, Hu Q, Ji W, Wright G, Gu Z. Leveraging Physiology for Precision Drug Delivery. Physiological Reviews 2017;97:189-225. [DOI: 10.1152/physrev.00015.2016] [Cited by in Crossref: 92] [Cited by in F6Publishing: 52] [Article Influence: 18.4] [Reference Citation Analysis]
18 Kryukov AI, Kunelskaya NL, Shershunova EA, Rebrov IE, Yamshchikov VA, Garov EV, Tsarapkin GY, Mishchenko VV. [Topical drug administration to the inner ear. Modern state of the problem and development perspectives]. Vestn Otorinolaringol 2019;84:6-14. [PMID: 31793520 DOI: 10.17116/otorino2019840516] [Reference Citation Analysis]
19 Nguyen K, Kempfle JS, Jung DH, Mckenna CE. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015). Expert Opinion on Therapeutic Patents 2017;27:191-202. [DOI: 10.1080/13543776.2017.1252751] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
20 Hwang SH, Gonzalez-Suarez AM, Stybayeva G, Revzin A. Prospects and Opportunities for Microsystems and Microfluidic Devices in the Field of Otorhinolaryngology. Clin Exp Otorhinolaryngol 2021;14:29-42. [PMID: 32772034 DOI: 10.21053/ceo.2020.00626] [Reference Citation Analysis]
21 Zhang K, Cheng X, Zhao L, Huang M, Tao Y, Zhang H, Rosenholm JM, Zhuang M, Chen ZY, Chen B, Shu Y. Direct Functional Protein Delivery with a Peptide into Neonatal and Adult Mammalian Inner Ear In Vivo. Mol Ther Methods Clin Dev 2020;18:511-9. [PMID: 32953927 DOI: 10.1016/j.omtm.2020.06.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]